Award
National Institute on Drug Abuse DA-20-183
Hemp-derived Cannabidiol for the treatment of cannabis use disorder in concentrate users: A double-blind placebo-controlled randomized trial
Recipient
UNIVERSITY OF COLORADO
Award Amount
$710,354.00
Ceiling
$710,354.00
Awarded
June 25, 2025
Identifier
DA-20-183
NIH grant awarded to University of Colorado for a multi-year randomized controlled trial studying hemp-derived cannabidiol for cannabis use disorder in concentrate users, totaling approximately $710,354.
Description
This is a NIH grant opportunity for research on hemp-derived CBD for cannabis use disorder. The project involves a randomized controlled trial with specific focus on CBD with and without THC. The award is for a multi-year project starting in 2023 and ending in 2028. The project is managed by Dr. L. Cinnamon Bidwell at the University of Colorado.